The CDK4-pRB-E2F1 pathway controls insulin secretion.

Abstract : CDK4-pRB-E2F1 cell-cycle regulators are robustly expressed in non-proliferating beta cells, suggesting that besides the control of beta-cell number the CDK4-pRB-E2F1 pathway has a role in beta-cell function. We show here that E2F1 directly regulates expression of Kir6.2, which is a key component of the K(ATP) channel involved in the regulation of glucose-induced insulin secretion. We demonstrate, through chromatin immunoprecipitation analysis from tissues, that Kir6.2 expression is regulated at the promoter level by the CDK4-pRB-E2F1 pathway. Consistently, inhibition of CDK4, or genetic inactivation of E2F1, results in decreased expression of Kir6.2, impaired insulin secretion and glucose intolerance in mice. Furthermore we show that rescue of Kir6.2 expression restores insulin secretion in E2f1(-/-) beta cells. Finally, we demonstrate that CDK4 is activated by glucose through the insulin pathway, ultimately resulting in E2F1 activation and, consequently, increased expression of Kir6.2. In summary we provide evidence that the CDK4-pRB-E2F1 regulatory pathway is involved in glucose homeostasis, defining a new link between cell proliferation and metabolism.
Liste complète des métadonnées

Littérature citée [29 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00418907
Contributeur : Yves Le Ster <>
Soumis le : vendredi 15 janvier 2010 - 08:10:29
Dernière modification le : mercredi 3 octobre 2018 - 16:02:13
Document(s) archivé(s) le : mardi 15 juin 2010 - 22:09:36

Fichiers

annicotte_ncb_2009.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Citation

Jean-Sébastien Annicotte, Emilie Blanchet, Carine Chavey, Irena Iankova, Safia Costes, et al.. The CDK4-pRB-E2F1 pathway controls insulin secretion.. Nature Cell Biology, Nature Publishing Group, 2009, 11 (8), pp.1017-23. 〈10.1038/ncb1915〉. 〈inserm-00418907〉

Partager

Métriques

Consultations de la notice

393

Téléchargements de fichiers

640